Otsu, Japan

Kunio Watanabe

This inventor holds 1 USPTO granted patent. Top assignee: Shionogi Company Limited. Active years: 1977.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kunio Watanabe. Retrieved from https://idiyas.com/inventor/kunio-watanabe-wf2mdm90

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1977

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kunio Watanabe: Innovator in Polypeptide Research

Introduction

Kunio Watanabe is a notable inventor based in Otsu, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of novel polypeptides. His work has implications for various medical applications, showcasing the importance of innovation in scientific research.

Latest Patents

Watanabe holds a patent for "Novel polypeptides having ACTH-like action." This patent describes a polypeptide of a specific formula that has potential therapeutic uses. His innovative approach to polypeptide design highlights the ongoing advancements in biopharmaceuticals.

Career Highlights

Watanabe is associated with Shionogi Company Limited, a prominent pharmaceutical company. His role at Shionogi has allowed him to collaborate with other talented researchers and contribute to groundbreaking projects in the field of medicine. His dedication to research and development has positioned him as a key figure in his area of expertise.

Collaborations

Throughout his career, Watanabe has worked alongside esteemed colleagues such as Ken Inouye and Masaru Shin. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Kunio Watanabe's contributions to polypeptide research exemplify the vital role of inventors in advancing medical science. His patent and collaborations reflect a commitment to innovation that continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…